14 June 2024
New antibiotic breaks resistance barrier.

All images are AI generated

Spread the love

New research from the University of Illinois Chicago and Harvard University has led to the development of an antibiotic that evades bacterial resistance. This breakthrough could provide medicine with a powerful new weapon against drug-resistant bacteria and the diseases they cause.

Keywords: New Antibiotic Resistance, Cresomycin, Ribosomes



Related Video

Published on: May 26, 2023 Description: Artificial intelligence (AI) was utilised by researchers to find a novel antibiotic that can eradicate a dangerous species of superbug.
New Superbug-killing antibiotic discovered | Latest World News | English News | WION
Play

New Antibiotic Resistance: Cresomycin Breaks Through Drug-Resistant Bacteria

In a groundbreaking development, scientists at the University of Illinois Chicago and Harvard University have collaborated to create a new antibiotic called cresomycin. This antibiotic has the potential to revolutionize medicine by providing a powerful weapon against drug-resistant bacteria and the diseases they cause. The research team’s findings were published in the journal Science, highlighting the efficacy of cresomycin in suppressing pathogenic bacteria that have developed resistance to commonly prescribed antimicrobial drugs.

Understanding Antibiotic Resistance and the Role of Ribosomes

Antibiotics have long been used to combat bacterial infections by targeting essential cellular processes. A key target for many antibiotics is the ribosome, a cellular structure responsible for protein synthesis. By interfering with the ribosome’s function, antibiotics can inhibit bacterial growth and ultimately kill the invading pathogens. However, bacteria have evolved various mechanisms to resist the actions of antibiotics, including modifying their ribosomes to defend against drug treatment.

One common defense mechanism involves the addition of a methyl group to the ribosomes, which disrupts the binding of antibiotics and hinders their efficacy. Through advanced imaging techniques such as X-ray crystallography, researchers were able to visualize the structural changes in drug-resistant ribosomes with remarkable precision. This led to the discovery of two defensive tactics employed by bacteria to evade antibiotic action, shedding light on the complex interplay between antibiotics and resistant bacteria.

The Development of Cresomycin: A Synthetic Solution to Antibiotic Resistance

In response to the challenges posed by bacterial resistance, the research team focused on designing a novel antibiotic that could overcome common forms of resistance. The result was cresomycin, a synthetic antibiotic that is preorganized to evade the methyl-group interference observed in drug-resistant ribosomes. By locking the drug into a shape optimized for binding to the ribosome, cresomycin effectively disrupts bacterial function and circumvents common mechanisms of drug resistance.

Cresomycin has shown promising results in animal experiments conducted at Harvard University, where it demonstrated protection against infections caused by multidrug-resistant strains of bacteria such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The next phase of research will involve evaluating the effectiveness and safety of cresomycin in human subjects, with the potential to pave the way for a new generation of antibiotics that can combat drug-resistant bacterial infections.

Structural Biology and the Future of Antibiotic Development

The development of cresomycin highlights the critical role that structural biology plays in the design of innovative antibiotics and other life-saving medications. By elucidating the molecular mechanisms underlying antibiotic resistance and evasion strategies, researchers can gain valuable insights into how to effectively target and overcome bacterial defenses. The detailed structural analysis provided by techniques like X-ray crystallography allows for the precise design of antibiotics that can bypass common resistance mechanisms, offering new hope in the ongoing battle against drug-resistant bacteria.

Wrapping up, the creation of cresomycin represents a significant milestone in the fight against antibiotic resistance, offering a promising new approach to combating drug-resistant bacterial infections. Through innovative research and collaboration, scientists are paving the way for the development of next-generation antibiotics that can effectively tackle the growing threat of antimicrobial resistance.

FAQ’s

What is cresomycin and how does it work?

Cresomycin is a new synthetic antibiotic that is designed to evade the common defense mechanisms used by bacteria to resist antibiotics. It works by locking into a shape that is optimized for binding to the ribosome, which is a cellular structure responsible for protein synthesis and a key target for many antibiotics.

Why is antibiotic resistance a problem?

Antibiotic resistance is a problem because it makes it difficult to treat bacterial infections. Bacteria have evolved various mechanisms to resist the actions of antibiotics, including modifying their ribosomes to defend against drug treatment. This means that antibiotics that were once effective may no longer work, leading to prolonged infections, treatment failures, and even death.

How did scientists develop cresomycin?

Scientists developed cresomycin by studying the structural changes in drug-resistant ribosomes using advanced imaging techniques such as X-ray crystallography. This allowed them to identify two defensive tactics employed by bacteria to evade antibiotic action. By designing a drug that could overcome these resistance mechanisms, they were able to create cresomycin.

What are the potential benefits of cresomycin?

Cresomycin has the potential to revolutionize medicine by providing a powerful weapon against drug-resistant bacteria and the diseases they cause. It has shown promising results in animal experiments, where it demonstrated protection against infections caused by multidrug-resistant strains of bacteria. The next phase of research will involve evaluating the effectiveness and safety of cresomycin in human subjects, with the potential to pave the way for a new generation of antibiotics that can combat drug-resistant bacterial infections.

What is the role of structural biology in antibiotic development?

Structural biology plays a critical role in the design of innovative antibiotics and other life-saving medications. By elucidating the molecular mechanisms underlying antibiotic resistance and evasion strategies, researchers can gain valuable insights into how to effectively target and overcome bacterial defenses. The detailed structural analysis provided by techniques like X-ray crystallography allows for the precise design of antibiotics that can bypass common resistance mechanisms, offering new hope in the ongoing battle against drug-resistant bacteria.

Links to additional Resources:

1. 1. > 20001.html. 

Related Wikipedia Articles

Topics: Cresomycin, Ribosome (cell), Antibiotic resistance

Cresomycin
Cresomycin is an experimental antibiotic. It binds to the bacterial ribosome in both Gram-negative and Gram-positive bacteria, and it has been found to be effective against multi-drug-resistant stains of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. It belongs to the bridged macrobicyclic oxepanoprolinamide antibiotics, which have similarities with lincosamides antibiotics....
Read more:
Cresomycin

Ribosome
Ribosomes () are macromolecular machines, found within all cells, that perform biological protein synthesis (messenger RNA translation). Ribosomes link amino acids together in the order specified by the codons of messenger RNA molecules to form polypeptide chains. Ribosomes consist of two major components: the small and large ribosomal subunits. Each...
Read more: Ribosome

Antimicrobial resistance
Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from the effects of antimicrobials (drugs used to treat infections). All classes of microbes can evolve resistance where the drugs are no longer effective. Fungi evolve antifungal resistance, viruses evolve antiviral resistance, protozoa evolve antiprotozoal resistance, and bacteria evolve...
Read more: Antimicrobial resistance

Leave a Reply

Your email address will not be published. Required fields are marked *